H.511 & S.54: Vermont's Two-Act Legalization

Vermont needed two separate laws and a 4-year gap to go from legalization to retail sales. Here's how the first legislative legalization in U.S. history unfolded — and why it took so long.

Last verified: March 2026

Act One: H.511 (Act 86) — Legalization Without Commerce

On January 22, 2018, Governor Phil Scott allowed H.511 to become law without his signature. This was a deliberate non-action — Scott had philosophical objections to legalization but recognized the legislature's will. The bill passed the House 81–63 and the Senate 20–9.

H.511 made Vermont the first state in American history to legalize cannabis through its legislature. Every prior state — Colorado, Washington, Oregon, Alaska, California, Nevada, Massachusetts, and Maine — had used voter ballot initiatives. Vermont proved it could happen through representative democracy.

But H.511 came with a critical limitation: no commercial sales whatsoever. The bill authorized only:

  • Possession of up to 1 ounce of flower or 5 grams of hashish for adults 21+
  • Home cultivation of 2 mature and 4 immature plants per household
  • Gifting up to 1 ounce between adults with no compensation

Effective July 1, 2018, Vermonters could legally grow and possess cannabis but had no legal way to buy it. This created a strange limbo that lasted more than four years.

Why No Sales? Governor Scott's Conditions

Governor Scott allowed H.511 to become law specifically because it excluded commercial sales. He had publicly stated he would veto any bill that included a retail framework until the state addressed two concerns:

  • Impaired driving: Scott wanted a reliable roadside test for cannabis impairment (which still doesn't exist anywhere)
  • Youth protection: He demanded comprehensive safeguards against underage access

Scott commissioned a study commission that ultimately recommended a commercial framework, but the governor remained cautious. It took two more years of legislative work to produce S.54.

Act Two: S.54 (Act 164) — Creating the Market

On October 7, 2020, Governor Scott signed S.54 (Act 164) into law, creating the Cannabis Control Board (CCB) and authorizing the commercial cannabis market. Key provisions included:

  • Creation of the CCB as the regulatory body with three board members
  • Seven license types: cultivator, manufacturer, retailer, testing lab, wholesaler, integrated, and dispensary
  • 14% excise tax plus 6% state sales tax (plus optional 1% local tax)
  • Social equity provisions and fee reductions for qualifying applicants
  • Municipal opt-in requirement — towns must affirmatively vote to allow retail

The 4-Year Gap: Why So Long?

Vermont's path from legalization (July 2018) to first retail sale (October 2022) was the longest gap of any legalization state. Several factors contributed:

Factor Impact
Governor Scott's reluctance Delayed the commercial bill by 2+ years after H.511
COVID-19 pandemic S.54 passed during the pandemic, slowing implementation
Understaffed CCB The board launched with just 4 employees to build an entire regulatory framework
Sequential licensing CCB processed cultivator licenses before retailer licenses, creating a bottleneck
Municipal opt-in Towns had to hold votes before retailers could even apply in their jurisdictions

October 1, 2022: The First Three Stores

After four years of waiting, Vermont's first three licensed retail stores opened on October 1, 2022. The market has since expanded to over 100 retailers, with 576 total licensees across all categories. Revenue grew from $108.66 million in 2023 to $139.24 million in 2024, with 2025 projections exceeding $160 million.

The CCB Today

The Cannabis Control Board is chaired by James Pepper, with board members Kyle Harris and Julie Hulburd (term expired). Executive Director Olga Fitch oversees operations. The CCB has grown significantly from its initial 4 employees but remains one of the smaller state cannabis agencies in the country.

What Came After: Act 166 and Beyond

The two-act framework has continued to evolve. Act 166 (2024) created the Medical-Use Endorsement, allowing existing retailers to serve medical patients. Act 56 (2025) refined licensing procedures. And S.278 (2026), which passed the Senate on March 26, proposes the most significant expansion yet: doubled possession limits, delivery permits, event consumption permits, and pioneering interstate commerce compacts.